TickerLeague

Revenue for AbbVie (ABBV)

According to AbbVie's latest reported financial statements, the company's current revenue (TTM) is $61.16B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

AbbVie Inc. logo
AbbVie

ABBV

TTM (last 4 quarters)

$61.16B

YoY change

+8.6%

5Y CAGR

+6.0%

Peak year (2025)

$61.16B

Cumulative revenue

$579.03B

Revenue history chart for AbbVie (ABBV) from 2009 to 2025

Revenue history table for AbbVie (ABBV) from 2009 to 2025

Fiscal yearPeriod endedReportedRevenueYoY
2025$61.16B+8.6%
2024$56.33B+3.7%
2023$54.32B-6.4%
2022$58.05B+3.3%
2021$56.20B+22.7%
2020$45.80B+37.7%
2019$33.27B+1.6%
2018$32.75B+16.1%
2017$28.22B+10.1%
2016$25.64B+12.2%
2015$22.86B+14.5%
2014$19.96B+6.2%
2013$18.79B+2.2%
2012$18.38B+5.4%
2011$17.44B+11.5%
2010$15.64B+10.0%
2009$14.21B

Revenue values are taken from AbbVie's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

As of the 2025 fiscal year, AbbVie (ABBV) reported revenue of $61.16B – grew 8.6% year-over-year.

AbbVie revenue has grown for 2 consecutive years, with a +6.0% compound annual growth rate over 2020–2025 (5 years).

Across the available history, revenue reached its high of $61.16B in 2025 and its low of $14.21B in 2009.

Among 8 Healthcare peers, AbbVie (ABBV) ranks 6th; the peer median for revenue is $65.09B.

AbbVie Revenue by Year

AbbVie Revenue 2025: $61.16B

AbbVie revenue in 2025 was $61.16B, grew 8.6% from 2024. This figure represents the highest annual value in the available history.

AbbVie Revenue 2024: $56.33B

AbbVie revenue in 2024 was $56.33B, edged up 3.7% from 2023.

AbbVie Revenue 2023: $54.32B

AbbVie revenue in 2023 was $54.32B, declined 6.4% below 2022.

AbbVie Revenue 2022: $58.05B

AbbVie revenue in 2022 was $58.05B, edged up 3.3% from 2021.

AbbVie Revenue 2021: $56.20B

AbbVie revenue in 2021 was $56.20B.

See more financial history for AbbVie (ABBV).

Sector peers — Revenue

Companies in the same sector as AbbVie, ranked by their latest revenue.

CompanyRevenueSector
UnitedHealth Group Incorporated (UNH)$447.57BHealthcare
Novo Nordisk A/S (NVO)$309.06BHealthcare
Johnson & Johnson (JNJ)$94.19BHealthcare
Eli Lilly and Company (LLY)$65.18BHealthcare
Merck & Co., Inc. (MRK)$65.01BHealthcare
AstraZeneca PLC (AZN)$58.74BHealthcare
Thermo Fisher Scientific Inc. (TMO)$44.56BHealthcare
Amgen Inc. (AMGN)$36.74BHealthcare

Frequently asked questions

What is AbbVie's revenue?

Latest reported revenue for AbbVie (ABBV) is $61.16B (period ending December 31, 2025).

How has AbbVie revenue changed year-over-year?

AbbVie (ABBV) revenue changed +8.6% year-over-year on the latest annual filing.

What is the long-term growth rate of AbbVie revenue?

AbbVie (ABBV) revenue compound annual growth rate is +6.0% over the most recent 5 years available.

When did AbbVie revenue hit its highest annual value?

AbbVie revenue reached its highest annual value of $61.16B in 2025.

What was AbbVie revenue in 2024?

AbbVie (ABBV) revenue in 2024 was $56.33B.

What was AbbVie revenue in 2025?

AbbVie (ABBV) revenue in 2025 was $61.16B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.